LifePoint, Inc. (LFPI)
LifePoint, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Ontario, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $31,294. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 82333.0%. Its beta of 3.29 implies it has historically moved more than the broad market.
LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical services (ambulances), retail pharmacies, public safety organizations, and the home healthcare sector. Established in 1992, the company was formerly known as US Drug Testing, Inc. until it adopted its current name, LifePoint, Inc., in February 1998. Its headquarters are situated in Ontario, California.
LifePoint, Inc. is most often compared with the following Healthcare names: